ロード中...
Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
BACKGROUND: Continuous administration of levodopa‐carbidopa intestinal gel (carbidopa‐levodopa enteral suspension) through a percutaneous endoscopic gastrojejunostomy is a treatment option for advanced Parkinson disease (PD) patients with motor fluctuations resistant to standard oral medications. Sa...
保存先:
| 出版年: | Mov Disord |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5064722/ https://ncbi.nlm.nih.gov/pubmed/26695437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26485 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|